Pseudokinases: update on their functions and evaluation as new drug targets

Byrne, Dominic P, Foulkes, Daniel M and Eyers, Patrick A ORCID: 0000-0002-9220-2966 (2017) Pseudokinases: update on their functions and evaluation as new drug targets. FUTURE MEDICINAL CHEMISTRY, 9 (2). pp. 245-265.

Text fmc-2016-0207.pdf - Published version Download (2MB)

Abstract

The pseudokinase complement of the human kinase superfamily consists of approximately 60 signaling proteins, which lacks one or more of the amino acids typically required to correctly align ATP and metal ions, and phosphorylate protein substrates. Recent studies in the pseudokinase field have begun to expose the biological relevance of pseudokinases, which are now thought to perform a diverse range of physiological roles and are connected to a multitude of human diseases, including cancer. In this review, we discuss how and why members of the 'pseudokinome' represent important new targets for drug discovery, and describe how knowledge of protein structure and function provides informative clues to help guide the rational chemical design or repurposing of inhibitors to target pseudokinases.

Item Type:	Article
Uncontrolled Keywords:	cancer, cysteine, cysteinome, disease, enzyme, inhibitor, kinase, kinome, pseudoenzyme, pseudokinase, signaling
Depositing User:	Symplectic Admin
Date Deposited:	26 Jan 2017 10:20
Last Modified:	19 Jan 2023 07:20
DOI:	10.4155/fmc-2016-0207
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3005395